bit.ly/3bcrixp
Here is a tweetorial on #MINOCA
🧲Class I Recommendations🧲
-> Use of Diagnostic algorithm
-> Use of #whyCMR
-> Use of working dx & Rx according to the underlying Dx
Given this limitation of the troponin bioassay, the “Fourth 4th Universal of MI" defined Injury from infarction
INJURY IS NECROSIS WITHOUT ISCHEMIA!
#ESCCongress
▶️ myocardial injury = nonischemic mechanisms of myocyte injury (eg, myocarditis),
▶️MI = ischemic mechanisms (eg,
plaque disruption or supply-demand mismatch).
#ESCCongress
bit.ly/3jn81Mu talks about TpNOCA to be inclusive of nonischemic causes
Important to acknowledge
MINOCA or TpNOCA - WORKING DIAGNOSIS
#whyCMR is the KEY to identify the diagnosis!
#ESCcongress
▶️ Overrepresentation in women and young
▶️ Prognosis guarded - Similar to 1-2 vessel CAD
▶️ To, Target the therapy (Now class I recommendation to do so!
#ESCCongress
Now the guidelines recommend the use of #intracoronary acetylcholine can be performed when the coronary or microvascular spasm is suspected
#IVUS or #OCT #radialfirst valuable ▶️ for thrombus, plaque rupture or erosion, or SCAD
#ESCCongress
#myocarditis as the leading cause on #whyCMR in patients with working diagnosis of #MINOCA
🧲 Since then many #whyCMR studies in the literature.
🧲#whyCMR able to identify etiology ~ 87% of the cases
#ESCCongress
The guidelines don't touch upon this however literature suggest best diagnostic yield within a week -- However robust diagnostic ability maintained up to ~3 months
(Can be done, OUTPATIENT)
#ESCCongress
▶️Prognostic data to indicate the change in the management with #whyCMR great study by @chiarabd
▶️ Also the poor level of agreement pre-#whyCMR diagnosis amongst clinicians
#ESCCongress
Guideline document cite this paper(1st slide)
▶️ limited date on Dual Antiplatelet
▶️ Use of ACE, BB, Statin based on the registry data (this registry didn't apply the current MINOCA criteria
MINOCA-BAT awaited!
#ESCCongress